KPIs & Operating Metrics(New)
Growth Metrics

Teradyne (TER) EBT (2016 - 2026)

Teradyne filings provide 18 years of EBT readings, the most recent being $465.7 million for Q1 2026.

  • On a quarterly basis, EBT rose 291.25% to $465.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $999.9 million, a 52.61% increase, with the full-year FY2025 number at $653.3 million, up 7.25% from a year prior.
  • EBT hit $465.7 million in Q1 2026 for Teradyne, up from $289.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $465.7 million in Q1 2026 to a low of $72.9 million in Q1 2024.
  • Median EBT over the past 5 years was $157.8 million (2024), compared with a mean of $182.0 million.
  • Biggest five-year swings in EBT: crashed 55.99% in 2025 and later soared 291.25% in 2026.
  • Teradyne's EBT stood at $195.2 million in 2022, then fell by 28.39% to $139.8 million in 2023, then grew by 12.87% to $157.8 million in 2024, then skyrocketed by 83.51% to $289.6 million in 2025, then surged by 60.81% to $465.7 million in 2026.
  • The last three reported values for EBT were $465.7 million (Q1 2026), $289.6 million (Q4 2025), and $148.1 million (Q3 2025) per Business Quant data.